A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.

Also called NCT01316094

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 165 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01316094
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01316094. Randomized; quadruple masking; primary purpose treatment. Start 2011-01-18 (actual); primary completion 2012-11-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
ASP1941
Intervention (Drug)
placebo
Lead sponsor
Astellas Pharma Inc (class: industry)

Record details

Record id
cardio:ct-nct01316094
Content hash
9c7f49b3459d2f5e359366fe323009fc0445b9418783155ba4795dbedaadc0c1